PubMed Health⌕ Search

Biomedical subjects

G J Garvey

Publications and source records attributed to G J Garvey.

10 recordsLinked to original sources
PubMed2001

Heavy metal hazards of Asian traditional remedies.

In recent years there has been an increase in the use of traditional Asian medicines. It is estimated that 30% of the US population is currently using some form of homeopathic or alternative therapy at a total cost of over $13 billion annually. Herbal medications are claimed and widely believed to be beneficial; however, there have been reports of acute and chronic intoxications resulting from their use. This study characterizes a random sampling of Asian medicines as to the content of arsenic, mercury, and lead. Traditional herbal remedies were purchased in the USA, Vietnam, and China. The Asian remedies evaluated contained levels of arsenic, lead, and mercury that ranged from toxic (49%) to those exceeding public health guidelines for prevention of illness (74%) when consumed according to the directions given in or on the package. Heavy metals contained in Asian remedies may cause illness of unknown origin and result in the consumption of health care resources that are attributable to other causes. The public health hazards of traditional herbal Asian remedies should be identified and disclosed.

Arsenic↗
PubMed1977

Incidence of diarrhea and colitis associated with clindamycin therapy.

A retrospective and prospective study was made of side effects in 200 patients who received clindamycin over a 15-month period. The incidence of gastrointestinal symptoms in this group of patients was 21.5%; of diarrhea, 13.5%; and of colitis, 2.5%. Factors associated with an increased incidence of diarrhea were older age and parenteral route of administration. Simultaneous use of other antibiotics, particularly aminoglycosides, and increased total dosage of clindamycin did not increase the incidence of diarrhea. The gastrointestinal side effects were usually self-limited if the drug was promptly discontinued and fluid support was provided.

Administration, Oral↗
PubMed1975

Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

The in vitro activity and human pharmacology of ticarcillin, a semisynthetic penicillin more active than carbenicillin against Pseudomonas, were compared. There has been no increase in resistance to ticarcillin of Pseudomonas strains over the past 5 years, but resistance of indole-positive Proteus and Serratia strains has been documented. After intramuscular (i.m.) injection of 1 g of ticarcillin, mean peak levels occurred at 1 h (26.9 mug/ml) with a decline over 6 h (6.8 mug/ml). Serum half-life was 84 min. Dilution of ticarcillin lidocaine reduced pain on i.m. injection but did not alter serum levels. Blood levels after 1 g i.m. are adequate to treat infections produced by Escherichia coli, Proteus mirabilis, and some Enterobacter, but not Pseudomonas. After rapid intravenous infusion of 3 and 5 g, mean peak serum levels of ticarcillin were slightly lower for 1 h than those achieved with carbenicillin. Probenecid administered before infusion produced increases in blood levels, half-lives, and volume of distribution. The biological half-life of ticarcillin was 72 min compared to 66 min with carbenicillin. There was a larger volume of distribution for ticarcillin than carbenicillin (15 liters versus 14 liters). The ticarcillin half-life when administered with probenecid was 108 min. Urinary recovery of ticarcillin was 77% against 95% of carbenicillin. However, approximately 10% of ticarcillin is recovered as penicilloic acid so that 95% of an intravenously administered dose is recovered.

Carbenicillin↗
PubMedDate not supplied

Achromobacter xylosoxidans bacteremia.

Achromobacter xylosoxidans is a rare cause of bacteremia. A case of community-acquired pneumonia and bacteremia due to Achromobacter in a patient with concomitant pulmonary tuberculosis is reported herein. The majority of patients who have developed achromobacter bacteremia have had a predisposition to infection (although the predisposing conditions have been diverse). Immunosuppression has been reported in only one of the seven patients with achromobacter bacteremia for whom detailed information is available. Achromobacter is usually resistant to ampicillin, cephalosporins, and aminoglycosides. Antipseudomonal penicillins and trimethoprim-sulfamethoxazole inhibit most isolates. Multiple-drug resistance is common, and optimal therapy is not known.

Alcaligenes↗